Your browser doesn't support javascript.
loading
Development and Implementation of Dried Blood Spot-based COVID-19 Serological Assays for Epidemiologic Studies
Marcus P Wong; Michelle Meas; Cameron Adams; Samantha Hernandez; Valerie Green; Magelda Montoya; Brett M Hirsch; Mary Horton; Hong Quach; Diana Quach; Xiaorong Shao; Indro Fedrigo; Alexandria Zermeno; Julia Huffaker; Raymond Montes; Alicia Madden; Sherri Cyrus; David McDowell; Phillip Williamson; Paul Contestable; Mars Stone; Josefina Coloma; Michael Paul Busch; Lisa Barcellos; Eva Harris.
Afiliación
  • Marcus P Wong; University of California, Berkeley, School of Public Health
  • Michelle Meas; University of California Berkeley, School of Public Health
  • Cameron Adams; University of California, Berkeley, School of Public Health
  • Samantha Hernandez; University of California, Berkeley, School of Public Health
  • Valerie Green; Creative Testing Solutions
  • Magelda Montoya; University of California, Berkeley, School of Public Health
  • Brett M Hirsch; Ortho Clinical Diagnostics
  • Mary Horton; University of California, Berkeley, School of Public Health
  • Hong Quach; University of California, Berkeley, School of Public Health
  • Diana Quach; University of California, Berkeley, School of Public Health
  • Xiaorong Shao; University of California, Berkeley, School of Public Health
  • Indro Fedrigo; University of California, Berkeley, School of Public Health
  • Alexandria Zermeno; University of California, Berkeley, School of Public Health
  • Julia Huffaker; University of California, Berkeley, School of Public Health
  • Raymond Montes; University of California, Berkeley, School of Public Health
  • Alicia Madden; University of California, Berkeley, School of Public Health
  • Sherri Cyrus; Creative Testing Solutions
  • David McDowell; Creative Testing Solutions
  • Phillip Williamson; Creative Testing Solutions
  • Paul Contestable; Ortho Clinical Diagnostics
  • Mars Stone; Vitalant Research Institiute
  • Josefina Coloma; University of California, Berkeley, School of Public Health
  • Michael Paul Busch; VITALANT RESEARCH INSTITUTE
  • Lisa Barcellos; University of California, Berkeley, School of Public Health
  • Eva Harris; University of California, Berkeley, School of Public Health
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21266786
Artículo de revista
Un artículo publicado en revista científica está disponible y probablemente es basado en este preprint, por medio del reconocimiento de similitud realizado por una máquina. La confirmación humana aún está pendiente.
Ver artículo de revista
ABSTRACT
Serological surveillance studies of infectious diseases provide population-level estimates of infection and antibody prevalence, generating crucial insight into population-level immunity, risk factors leading to infection, and effectiveness of public health measures. These studies traditionally rely on detection of pathogen-specific antibodies in samples derived from venipuncture, an expensive and logistically challenging aspect of serological surveillance. During the COVID-19 pandemic, guidelines implemented to prevent the spread of SARS-CoV-2 infection made collection of venous blood logistically difficult at a time when SARS-CoV-2 serosurveillance was urgently needed. Dried blood spots (DBS) have generated interest as an alternative to venous blood for SARS-CoV-2 serological applications due to their stability, low cost, and ease of collection; DBS samples can be self-generated via fingerprick by community members and mailed at ambient temperatures. Here, we detail the development of four DBS-based SARS-CoV-2 serological methods and demonstrate their implementation in a large serological survey of community members from 12 cities in the East Bay region of the San Francisco metropolitan area using at- home DBS collection. We find that DBS perform similarly to plasma/serum in enzyme-linked immunosorbent assays and commercial SARS-CoV-2 serological assays. In addition, we show that DBS samples can reliably detect antibody responses months post-infection and track antibody kinetics after vaccination. Implementation of DBS enabled collection of valuable serological data from our study population to investigate changes in seroprevalence over an eight-month period. Our work makes a strong argument for the implementation of DBS in serological studies, not just for SARS-CoV-2, but any situation where phlebotomy is inaccessible.
Licencia
cc_by_nc_nd
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Preprint
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Preprint